| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |